Oct 22, 2019 / 01:00PM GMT
Operator
Good day and welcome to the bioMérieux Q3 2019 Business Review Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Morgeau. Please go ahead, sir.
Sylvain Morgeau - bioMérieux S.A.-IR
Thank you. Good afternoon, and thank you for joining us to review bioMérieux' performance for this third quarter of 2019. As usual, I am online with Alexandre Mérieux, Chairman and CEO, as well as Guillaume Bouhours, CFO.
So before handing the call over to Alexandre for preliminary remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer saying that the forward-looking statements are based entirely or partially on assessments or judgments that may change or be modified due to uncertainties and risks related to the company's environment, notably those that are described in the 2018 registration document, including but not limited to economic conditions, financial exposure to currency
Q3 2019 Biomerieux SA Business Review Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot